Amarin Corp Plc (AMRN)

[JRoon71]

If there is no shot of ever reversing the Du decision, or mitigating the infringement via backdoor channels (insurance co's and PBM's), rather than putting out an authorized generic, as many have proposed, why not strike a deal with the generics to become their suppliers, in exchange for their agreement to limit their distribution to MARINE indication (ie. agree to a formal change in labeling)?

This ends the feud, avoids the potential dead inventory dilemma brewing, allows us to resume marketing the CVD indication in the U.S., and also avoids the potential negative implications overseas of Amarin distributing a generic.

Basically, give away the MARINE indication in the U.S. in exchange for strong confirmation that we own the R-It indication. Not the perfect solution, but better than our current situation.

Of course, this all might be moot if the real plan is to get the company sold in the next year or two and that a BP might be in a better position to fight the generics.